Shenwei Pharmaceutical (02877) rose more than 6% after earnings. As of press release, it rose 6.04% to HK$9.3, with a turnover of HK$2,505,900.
The Zhitong Finance App learned that Shenwei Pharmaceutical (02,877) rose more than 6% after profit. As of press release, it had risen 6.04% to HK$9.3, with a turnover of HK$2,505,900.
According to the news, Shenwei Pharmaceutical announced that the profit attributable to company owners for the year ended December 31, 2023 is expected to increase by about 30% to 36% over the same period last year, and the profit attributable to company owners in 2022 is about 723 million yuan. The expected increase in net profit is mainly due to a 14% increase in the Group's overall sales revenue compared to last year and a decrease of about 2 to 3 percentage points in the ratio of sales and distribution costs to turnover compared to last year.